Home
Scholarly Works
Activity of cediranib (AZD2171) in patients (pts)...
Conference

Activity of cediranib (AZD2171) in patients (pts) with previously untreated metastatic renal cell cancer (RCC). A phase II trial of the PMH Consortium

Authors

Sridhar SS; Mackenzie MJ; Hotte SJ; Mukherjee SD; Kollmannsberger C; Haider MA; Chen EX; Wang L; Srinivasan R; Ivy SP

Volume

26

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2008

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team